TAIWAN LIPOSOME CO. LTD.;TLC BIOPHARMACEUTICALS, INC.
发明人:
LIN, YI FONG,林一峰,KAN, PEI,甘霈,HONG, KEELUNG,洪基隆
申请号：
TW096135639
公开号：
TWI386209B
申请日:
2007.09.21
申请国别(地区):
TW
年份:
2013
代理人:
摘要：
An emulsion composition includes prostaglandin E1 (PGE1), a phospholipid with a high purity and a non-proton-providing surfactant that improves stability of PGE1. Embodiments of the emulsion composition include an effective amount of PGE1, about 1% to about 30% (w/w) of a pharmaceutically acceptable oil as an oil base based on the weight of the emulsion composition, about 1% to about 30% (w/w) of a phospholipid with a high purity based on the weight of the oil base, about 1.6% to about 40% (w/w) of a non-proton-providing surfactant based on the weight of the oil base, and the balance of the emulsion composition being water.一種乳化組成物，其包括前列腺素E1(Prostaglandin E1，PGE1)、高純度磷脂及可增進PGE1之安定性之非提供質子之界面活性劑。該乳化組成物之具體實施例包括：有效量之PGE1、為該乳化組成物重量之約1%至約30%(w/w)之醫藥可接受油以作為油基劑、為該油基劑重量之約1%至約30%(w/w)之高純度磷脂、為該油基劑重量之約1.6%至約40%(w/w)之非提供質子之界面活性劑，以及該乳化組成物之餘量為水。
